Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix

International Journal of Gynecological Cancer

Volumn 22, Issue 1, 2012, Pages 115-122

  Singh, Piksi ^a   Tripcony, Lee ^a   Nicklin, James ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Adjuvant treatment; Cervix cancer; Early stage disease; Overall survival; Recurrent disease; Relapse free survival; Salvage survival; Site of recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; TREATMENT FAILURE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LINEAR MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84858247711     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822fa8bb     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistic. CA Cancer J Clin. 2009;59:225-249.
2. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3.
3. Hacker NF. Cervical cancer. In: Berek JS, Hacker NF, eds. Practical Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:337-396.
4. Jiménez de la Peña M, Martínez de Vega Fernández V, Recio Rodríguez M, et al. Current imaging modalities in the diagnosis of cervical cancer. Gynecol Oncol. 2008;110:S49-S54.
5. Lemke U, Hamm B. Pretreatment diagnostic evaluation of cervical cancer. Rofo. 2009;181:433-440.
6. Grigsby PW. PET/CT imaging to guide cervical cancer therapy. Future Oncol. 2009;7:953-958.
7. Nahhas WA, Sharkey FE, Whitney CW, et al. The prognostic significance of vascular channel involvement and deep stromal penetration in early cervical carcinoma. Am J Clin Onco. 1983;6:259-264. (Pubitemid 13057936)
8. Metindir J, Bilir G. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy. Eur J Gynaecol Oncol. 2007;28:28-32. (Pubitemid 46408227)
9. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352.
10. Takeda N, Sakuragi N, Takeda M, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81:1144-1151. (Pubitemid 35454363)
11. Memarzadeh S, Natarajan S, Dandade DP, et al. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet Gynecol. 2003;102:612-619. (Pubitemid 37314013)
12. Kristensen GB, Abeler VM, Risberg B. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 1999;74:245-251. (Pubitemid 29377220)
13. Park JY, Kim DY, Kim JH, et al. Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol. 2010;117:53-58.
14. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999;73:177.
15. Rotman M, Sedlis A, Piedmonte MR, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65:169.
16. Rogers L, Siu SS, Luesley D, et al. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer. Cochrane Database Syst Rev. 2009;4:CD007583.
17. Ayhan A, Al RA, Baykal C, et al. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer. 2004;14:286-292. (Pubitemid 38533900)
18. Lai CH, Hong JH, Hsueh S, et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer. 1999;85:1537-1546. (Pubitemid 29152826)
19. Lahousen M, Haas J, Pickel H, et al. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecol Oncol. 1999;73:196-201. (Pubitemid 29215731)